SuperworthNeuphoria Therapeutics shares outstanding NEUP
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 5.4M
- On a year earlier
- +184.4%
- more shares
Neuphoria Therapeutics had 5.4M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 184.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 5.4M | +184% |
| FY2025 | 1.9M | −12% |
| FY2024 | 2.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 5.4M | +184% | |
| Q3 FY26 | 5.4M | +215% | |
| Q2 FY26 | 4.5M | +188% | |
| Q1 FY26 | 2.2M | +73% | |
| Q4 FY25 | 1.9M | −12% | |
| Q3 FY25 | 1.7M | +75% | |
| Q2 FY25 | 1.6M | +84% | |
| Q1 FY25 | 1.3M | +943% | |
| Q4 FY24 | 2.2M | n/a | |
| Q3 FY24 | 981K | n/a | |
| Q2 FY24 | 857.3K | n/a | |
| Q1 FY24 | 124.7K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Neuphoria Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.